TrovaGene Inc (TROV) Sees Bridger Management Buy More Shares; Other Stocks Roberto Mignone Loves

Another large position in Bridger’s equity portfolio is represented by Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), a $55 billion pharmaceutical and drug company. The fund held 1.49 million shares of the company, up by 23% on the quarter, the value of the stake amounting to $85.40 million. Among 737 funds that we track, 67 investors reported ownership of Teva Pharmaceutical shares in the previous round of 13F filings, including 10 funds managed by billionaires. Sean Cullinan’s Point State Capital is the largest shareholder of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) among funds that we track, disclosing ownership of 8.09 million shares in its last 13F filing. Billionaire George Soros is also invested in the pharmaceutical company, holding 4.86 million shares as of the end of 2014, the $279.50 million stake being the third-largest in Soros Fund Management‘s equity portfolio.

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has the largest sales of generic drugs in terms of revenue of any pharmaceutical company in the world. In its latest financial report, the company posted a slight decrease in revenue to $20.27 billion for 2014, from $20.31 billion a year earlier, mainly impacted by currency fluctuations. However, the company’s earnings grew strongly to $3.56 per diluted share from $1.49 a year earlier. The revenue growth comes on the back of significant cost cutting initiatives adopted by the company, which also softened the decline in sales.

Bridger’s third-largest holding in terms of value is represented by KAR Auction Services Inc (NYSE:KAR), a provider of a used cars auction service in the US. The fund kept the stake unchanged at 2.40 million shares worth $83.16 million at the end of 2014. In the last quarter of 2014, the company reported a profit of $0.35 per share, versus a loss of $0.13 per share a year earlier. Its revenue also increased to around $601 million from $541 million. For the full year, the company’s earnings surged to $1.19 per share from $0.48 per share a year earlier on revenue of $2.37 billion, up from $1.82 billion a year earlier. For 2015, KAR Auction Services Inc (NYSE:KAR) expects its earnings to land in a range between $1.40 and $1.55 per share. Billionaire Leon Cooperman of Omega Advisors is another investor bullish on KAR Auction Services Inc (NYSE:KAR) raising his stake by 15% to 3.38 million shares during the previous quarter. Meanwhile, the company’s stock has gained some 7.7% since the beginning of 2015.

Disclosure: None